At SALESEER, we are recognized for our critical thinking, unbiased approach, and data independence.
We leverage deep clinical expertise and strategic industry knowledge to help clients navigate complex clinical and commercial challenges. Through the intelligent application of real-world data, clinical insights, and market intelligence, we empower informed decision-making across discovery, research, market access, and commercial strategy.
At SALESEER, we understand that value creation occurs at the intersection of insight and action.
Founded in 2011, SALESEER is a privately held, women-owned enterprise headquartered in Houston, Texas.
Social Determinants of Health (SDoH) are essential for understanding a patient’s social, economic, and demographic characteristics which support personalized patient care.
Inclusion of SDoH data in clinical and market research provides a complete basis for targeted, informed decision making, supporting of equitable care, and outreach that meet patients where they are—socially, economically, and culturally.
Our SDoH dataset includes more than 275 million unique adults—covering over 92% of the U.S. adult population. With hundreds of rich data fields, including education level, marital status, income, housing and vehicle ownership, employment status, primary language, and more, we provide a comprehensive view of the non-medical factors that influence health.
Delayed patient access to appropriate care is a complex problem. To combat this issue, in partnership with FinThrive and their data for over 400 hospitals, saleSEER has co-developed an innovative, interactive ready-to-use dashboard called Barriers to Access (BTA).
The value to life sciences includes:
This information affords life sciences a way to address the reasons that patients are not getting the treatment they
need when they need it.
We provide access to a wide range of healthcare data including EMR, Unstructured with Labs, Chargemaster, Claims, Remits, and Specialty Pharmacy. Our deep understanding of all data types, by treatment environment, enables us to make recommendations that align precisely with client objectives.
While oncology remains our foundation, our data spans all therapeutic areas including behavioral health and rare diseases.
ClinicalPath oncology pathways by Elsevier (formerly Via Oncology) provides evidence-based treatment recommendations covering over 95% of cancer types. As the exclusive supplier of ClinicalPath in the US since 2012, our team has the insights that maximize the return on investment for our clients.
We understand how to prepare clinical evidence for Disease Committee consideration, why therapies are recommended or not, the clinical evidence behind them, and how commercial teams can use this information to support market strategy. Our team provides actionable recommendations to support and enhance your oncology pathway strategy.
Derived from the Dutch word “zoek” meaning “to search,” DATAZOEK (pronounced da-ta-zook) is SALESEER’s proprietary software designed to unlock the value hidden in unstructured data.
With DATAZOEK, users can extract key information from text, PDFs, and images; redact sensitive content; and convert documents into structured, searchable text—automating data completeness and enrichment with speed and accuracy.